René Carvajal, Ana Zabalza, Pere Carbonell-Mirabent, Xavier Martínez-Gómez, Juliana Esperalba, Agustín Pappolla, Ariadna Rando, Alvaro Cobo-Calvo, Carmen Tur, Marta Rodriguez, Jordi Río, Manuel Comabella, Joaquín Castilló, José Ángel Rodrigo-Pendás, Nathane Braga, Neus Mongay-Ochoa, Claudia Guío-Sánchez, Ángela Vidal-Jordana, Georgina Arrambide, Breogán Rodríguez-Acevedo, Luciana Midaglia, Blanca Borras-Bermejo, Ingrid Galán, Jaume Sastre-Garriga, Xavier Montalban, Susana Otero-Romero, Mar Tintoré
IMPORTANCE: Vaccination in patients with highly active multiple sclerosis (MS) requiring prompt treatment initiation may result in impaired vaccine responses and/or treatment delay. OBJECTIVE: To assess the immunogenicity and safety of inactivated vaccines administered during natalizumab treatment. DESIGN, SETTING, AND PARTICIPANTS: This self-controlled, prospective cohort study followed adult patients with MS from 1 study center in Spain from September 2016 to February 2022...
April 1, 2024: JAMA Network Open